THE latest issue of the NPS
Radar has been released online,
containing independent, evidencebased
assessments of new drugs
and new PBS listings.
This month’s issue covers two of
the new class of dipeptidyl
peptidase-4 (DPP-4) inhibitors
sitagliptin (Januvia) and vildagliptin
(Galvus), as well as the new
autoinjector Anapen and reviews
and info on Panadol Extra,
Colchicine for acute gout,
pramipexole (Sifrol ER), Anakinra
(Kineret) and Exenatide (Byetta).
See www.nps.org.au/radar.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.